Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy

NCT06425419 is registered in ClinicalTrials.gov with Massachusetts Eye and Ear Infirmary as lead sponsor.

NCT NCT06425419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06425419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of Intravitreal Topotecan for the Treatment of Proliferative Vitreoretinopathy
Lead sponsor
Massachusetts Eye and Ear Infirmary
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 1, 2028
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

proliferative vitreo-retinopathy, proliferative vitreoretinopathy, rhegmatogenous retinal detachment